Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Nalini Vadivelu, Alice Kai, Benjamin Maslin, Gopal Kodumudi, Aron Legler & Jack M Berger. (2015) Tapentadol extended release in the management of peripheral diabetic neuropathic pain. Therapeutics and Clinical Risk Management 11, pages 95-105.
Read now
Read now
Articles from other publishers (19)
Tonghui Zhang, Ling Wang & Ling Chen. (2022) Alleviative effect of microRNA-497 on diabetic neuropathic pain in rats in relation to decreased USP15. Cell Biology and Toxicology.
Crossref
Crossref
Prabhakar Busa, Yaswanth Kuthati, Niancih Huang & Chih-Shung Wong. (2022) New Advances on Pathophysiology of Diabetes Neuropathy and Pain Management: Potential Role of Melatonin and DPP-4 Inhibitors. Frontiers in Pharmacology 13.
Crossref
Crossref
Emma Gray, Xin Ye, Yen-Feng Wang & Shuu-Jiun Wang. (2021) Cost-Effectiveness of Mirogabalin for the Treatment of Diabetic Peripheral Neuropathic Pain in Taiwan. Value in Health Regional Issues 24, pages 148-156.
Crossref
Crossref
Ruchi Tiwari, Pranay Wal, Priya Singh, Gaurav Tiwari & Awani Rai. (2021) A Review on Mechanistic and Pharmacological Findings of Diabetic Peripheral Neuropathy including Pharmacotherapy. Current Diabetes Reviews 17:3, pages 247-258.
Crossref
Crossref
Pratishtha Singh, Seema Bansal, Anurag Kuhad, Anil Kumar & Kanwaljit Chopra. (2020) Naringenin ameliorates diabetic neuropathic pain by modulation of oxidative-nitrosative stress, cytokines and MMP-9 levels. Food & Function 11:5, pages 4548-4560.
Crossref
Crossref
Alberto J. Pérez-Panero, María Ruiz-Muñoz, Antonio I. Cuesta-Vargas & Manuel Gónzalez-Sánchez. (2019) Prevention, assessment, diagnosis and management of diabetic foot based on clinical practice guidelines. Medicine 98:35, pages e16877.
Crossref
Crossref
Andrew J. Nasr & Jason Zafereo. (2019) The effects of dry needling and neurodynamic exercise on idiopathic peripheral neuropathy: A case report. Journal of Bodywork and Movement Therapies 23:2, pages 306-310.
Crossref
Crossref
Ting-Ting Zhang, Rui Xue, Shi-Yong Fan, Qiong-Yin Fan, Lei An, Juan Li, Lei Zhu, Yu-Hua Ran, Li-Ming Zhang, Bo-Hua Zhong, Yun-Feng Li, Cai-Ying Ye & You-Zhi Zhang. (2018) Ammoxetine attenuates diabetic neuropathic pain through inhibiting microglial activation and neuroinflammation in the spinal cord. Journal of Neuroinflammation 15:1.
Crossref
Crossref
Mendel Jansen, Jeanne Mendell, Alexander Currie, James Dow, Ling He, Domenico Merante, Victor Dishy, Hitoshi Ishizuka & Hamim Zahir. (2018) Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Mirogabalin When Coadministered With Lorazepam, Zolpidem, Tramadol, or Ethanol: Results From Drug-Drug Interaction Studies in Healthy Subjects. Clinical Pharmacology in Drug Development 7:6, pages 597-612.
Crossref
Crossref
Tracey A Ignatowski & Robert N Spengler. (2018) Targeting tumor necrosis factor in the brain relieves neuropathic pain. World Journal of Anesthesiology 7:2, pages 10-19.
Crossref
Crossref
Domenico Merante, Julio Rosenstock, Uma Sharma, Karen Feins, Ching Hsu & Aaron Vinik. (2017) Efficacy of Mirogabalin (DS-5565) on Patient-Reported Pain and Sleep Interference in Patients with Diabetic Neuropathic Pain: Secondary Outcomes of a Phase II Proof-of-Concept Study. Pain Medicine.
Crossref
Crossref
Hadas Nahman-Averbuch, Elliot Sprecher, Giris Jacob & David Yarnitsky. (2016) The Relationships Between Parasympathetic Function and Pain Perception: The Role of Anxiety. Pain Practice 16:8, pages 1064-1072.
Crossref
Crossref
Tejal Patel, Feng Chang, Heba Tallah Mohammed, Lalitha Raman-Wilms, Jane Jurcic, Ayesha Khan & Beth Sproule. (2016) Knowledge, Perceptions and Attitudes toward Chronic Pain and Its Management: A Cross-Sectional Survey of Frontline Pharmacists in Ontario, Canada. PLOS ONE 11:6, pages e0157151.
Crossref
Crossref
Daiany D.B. Redivo, Anne K. Schreiber, Eliana R. Adami, Deidiane E. Ribeiro, Samia R.L. Joca, Janaína M. Zanoveli & Joice M. Cunha. (2016) Effect of omega-3 polyunsaturated fatty acid treatment over mechanical allodynia and depressive-like behavior associated with experimental diabetes. Behavioural Brain Research 298, pages 57-64.
Crossref
Crossref
Kelsey Juster-Switlyk & A. Gordon Smith. (2016) Updates in diabetic peripheral neuropathy. F1000Research 5, pages 738.
Crossref
Crossref
Mei Yang, Chunlin Qian & Yifei Liu. (2015) Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States. Pain Medicine 16:11, pages 2075-2083.
Crossref
Crossref
Meryl Brod, Betsy Pohlman, Steven I. Blum, Abhilasha Ramasamy & Robyn Carson. (2014) Burden of Illness of Diabetic Peripheral Neuropathic Pain: A Qualitative Study. The Patient - Patient-Centered Outcomes Research 8:4, pages 339-348.
Crossref
Crossref
Michelle Kaku, Aaron Vinik & David M. Simpson. (2015) Pathways in the Diagnosis and Management of Diabetic Polyneuropathy. Current Diabetes Reports 15:6.
Crossref
Crossref
Nuria Cobacho, José Luis de la Calle & Carlos Luis Paíno. (2014) Dopaminergic modulation of neuropathic pain: Analgesia in rats by a D2-type receptor agonist. Brain Research Bulletin 106, pages 62-71.
Crossref
Crossref